查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
细胞化验分析及高内涵筛选的全球市场:用户，各产品预测 - 附执行顾问指南(2025年～2029年)
市场调查报告书
商品编码
1597907

细胞化验分析及高内涵筛选的全球市场:用户，各产品预测 - 附执行顾问指南(2025年～2029年)

Cell Based Assay & High Content Screening Markets. Forecasts by User and Product. With Executive and Consultant Guides. 2025 to 2029
出版日期: | 出版商: Howe Sound Research | 英文 281 Pages | 商品交期: 最快1-2个工作天内

价格

基于细胞的检测是药物开发和科学研究的支柱，目前正在恢復大流行后研究活动。此外，新技术使得基于细胞的检测能够用于测量细胞功能的各个方面。这个市场还在不断成长。製药业的支柱正成为生物技术的核心。

本报告提供全球细胞化验分析及高内涵筛选市场相关调查，提供市场概要，以及用户，各产品趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 市场指南

第2章 简介和市场定义

  • 细胞化验分析是什么
  • 临床试验的失败
  • 感染疾病基于完成大的作用
  • 市场定义
  • 调查手法
  • 美国的医疗市场与医药品调查费- 预测

第3章 细胞化验分析-技术指南

  • 细胞培养
  • 细胞化验
  • 细胞存活率化验
  • 细胞生长化验
  • 细胞毒性化验
  • 细胞老化化验
  • 细胞凋亡
  • 自动模糊
  • 坏死
  • 氧化压力
  • 2D对3D
  • 信号传达途径，GPCR
  • 免疫调节与抑制
  • 报导基因技术
  • CBA设计·开发
  • 细胞化验分析- 要点

第4章 产业概要

  • 市场进入机关
    • 学术研究机关
    • CRO
    • 基因设备供应商
    • 细胞分离及观察供应商
    • 细胞株及试剂供应商
    • 製药公司
    • 审核机关
    • 认证机关

第5章 市场趋势

  • 成长促进因素
  • 阻碍成长的要素
  • 技术开发

第6章 细胞化验分析的最近的趋势

第7章 主要企业的简介

  • Abcam
  • Agilent
  • Aurora Biomed
  • Axxam
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • Berkley Lights
  • BioIVT
  • Bio-Rad Laboratories, Inc.
  • BMG Labtech
  • Bruker
  • Cell Biolabs, Inc.
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories
  • Corning, Inc.
  • Cytek Biosciences
  • Cytovale
  • Deepcell
  • Enzo Biochem
  • Eurofins DiscoverX Corporation
  • Evotec AG
  • Excellerate Bioscience
  • Fujifilm Cellular Dynamics International
  • Genedata
  • Hemogenix
  • Invivogen
  • Leica Biosystems
  • Lonza Group Ltd.
  • Luminex Corp(DiaSorin)
  • Merck & Co., Inc
  • Miltenyi Biotec
  • Molecular Devices
  • Nanion
  • Ncardia
  • New England Biolabs, Inc.
  • Novogene Bioinformatics Technology Co., Ltd.
  • Olympus
  • Origene Technologies
  • Promega
  • Qiagen
  • Reaction Biology
  • Recursion Pharma
  • Revvity
  • Roche Diagnostics
  • Sartorius
  • Sartorius-ForteBio
  • Sartorius-IntelliCyt
  • Singleron Biotechnologies
  • Sony Biotechnology
  • SPT Labtech
  • Stemcells Technologies Canada Inc.
  • Tecan
  • Thermo Fisher Scientific Inc.
  • Vitro Biopharma

第8章 全球市场规模

  • 全球市场概要，各国
  • 全球市场概要，各用户
  • 全球市场概要，各产品

第9章 全球市场，各用户

  • 製药公司
  • 研究机关
  • 产业/化妆品

第10章 细胞化验分析，各产品

  • 设备
  • 试剂
  • 服务
  • 软体

第11章 附录

Report Overview:

Cell Based Assays are a mainstay of drug development and scientific research, and now, post pandemic, research activity is rebounding. On top of this new technology is allowing Cell Based Assays to be used to measure any aspect of cell function. This market just keeps on growing with no end in sight. The workhorse of the pharmaceutical industry is becoming a central player in biotechnology.

This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.

The technology is moving faster than the market. Genomics and Immunology are playing a role too. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.

Table of Contents

1. Market Guides

  • 1.1. Situation Analysis
  • 1.2. Guide for Executives and Marketing Staff
  • 1.3. Guide for Investment Analysts and Management Consultants

2. Introduction and Market Definition

  • 2.1. What are Cell Based Assays?
  • 2.2. Clinical Trial Failures
    • 2.2.1. Immuno-oncology Plays a Leading Role in Cell Based Assays
  • 2.3. Infectious Disease Will Play a Larger Role
  • 2.4. Market Definition
    • 2.4.1. Market Size
    • 2.4.2. Currency
    • 2.4.3. Years
  • 2.5. Methodology
    • 2.5.1. Methodology
    • 2.5.2. Sources
    • 2.5.3. Authors
  • 2.6. U.S. Medical Market and Pharmceutical Research Spending - Perspective
    • 1.5.1. U.S. Expenditures for Pharmaceutical Research

3. Cell Based Assays - Guide to Technology

  • 3.1. Cell Cultures
    • 3.1.1. Cell Lines
    • 3.1.2. Primary Cells
    • 3.1.3. Stem Cells
    • 3.1.4. iPSC's - The Special Case
  • 3.2. Cell Assays
  • 3.3. Cell Viability Assays
  • 3.4. Cell Proliferation Assays
  • 3.5. Cytotoxicity Assays
  • 3.6. Cell Senescence Assays
  • 3.7. Apoptosis
  • 3.8. Autophagy
  • 3.9. Necrosis
  • 3.10. Oxidative Stress
  • 3.11. 2D vs. 3D
  • 3.12. Signalling Pathways, GPCR
  • 3.13. Immune Regulation & Inhibition
  • 3.14. Reporter Gene Technology
  • 3.15. CBA Design & Development
  • 3.16. Cell Based Assays - The Takeaway

4. Industry Overview

  • 4.1. Players in a Dynamic Market
    • 4.1.1. Academic Research Lab
    • 4.1.2. Contract Research Organization
    • 4.1.3. Genomic Instrumentation Supplier
    • 4.1.4. Cell Separation and Viewing Supplier
    • 4.1.5. Cell Line and Reagent Supplier
    • 4.1.6. Pharmaceutical Company
    • 4.1.7. Audit Body
    • 4.1.8. Certification Body

5. Market Trends

  • 5.1. Factors Driving Growth
    • 5.1.1. Candidate Growth
    • 5.1.2. Immuno-oncology
    • 5.1.3. Genomic Blizzard
    • 5.1.4. Technology Convergence
    • 5.1.5. The Insurance Effect
  • 5.2. Factors Limiting Growth
    • 5.2.1. CBA Development Challenges
    • 5.2.2. Instrument Integration
    • 5.2.3. Protocols
  • 5.3. Technology Development
    • 5.3.1. 3D Assays
    • 5.3.2. Automation
    • 5.3.3. Software
    • 5.3.4. Primary Cells
    • 5.3.5. Signalling and Reporter Genes
    • 5.3.6. The Next Five Years

6. Cell Based Assays Recent Developments

  • 6.1. Recent Developments
    • 6.1.1. Importance of These Developments
    • 6.1.2. How to Use This Section
  • 6.2. New cell-based Screening Panel
  • 6.3. New platform will accelerate single-cell analysis workflow
  • 6.4. CytoTronics Announces Pixel Octo
  • 6.5. Cell Painting boosts high-throughput screening
  • 6.6. Castle Biosciences Sees Big Gains in New Testing Niches
  • 6.7. Cell-Based Assay Outperforms Others
  • 6.8. 3D spheroid model Monitors T-cell invasion
  • 6.9. BioAuxilium Launches New Biomarker Assay
  • 6.10. Charles River Laboratories Acquires SAMDI Tech
  • 6.11. Axion BioSystems Launches New High-Throughput Live-Cell Imaging Platform
  • 6.12. Fujifilm's Life Sciences Invests in PhenoVista Biosciences
  • 6.13. Nucleai Launches New Multiplex Imaging Spatial Analysis Solution
  • 6.14. BIO-TECHNE ANNOUNCES MULTI-OMIC RNASCOPE ASSAYS
  • 6.15. Indivumed, CellPhenomics Partner on Cancer Drug Target Research
  • 6.16. Synthego to Accelerate Drug Discovery
  • 6.17. Long COVID Detected By Cell-Based Assay
  • 6.18. Nanolive closes a USD 20 million Funding Round
  • 6.19. Depixus Seeks to Commercialize 'Magnetic Tweezers' for Drug Discovery
  • 6.20. BioAuxilium Research Expands its Cell Signaling Assay Portfolio
  • 6.21. Droplet Genomics Debuts New Microfluidic Screening Platform
  • 6.22. DLP Plus Single-Cell Sequencing Method Spreads From Canada to Cancer Labs Worldwide
  • 6.23. Secondcell Bio to Make Creation of Cell Lines Easy
  • 6.24. Nanolitre-scale cell assays developed with droplet microarraymass spec
  • 6.25. Thermo Fisher Scientific Acquires Cell Sorting Technology
  • 6.26. Cellink to Distribute Phasefocus High-Content Cell Imaging Platform
  • 6.27. Axxam and FUJIFILM Cellular Dynamics Announce Strategic Alliance
  • 6.28. Cancer Genetics to Acquire Organoid Startup Stemonix
  • 6.29. Curi Bio Acquires Artificial Intelligence Firm Dana Solutions
  • 6.30. CRISPR Screens Uncover Novel Cancer Therapy Targets
  • 6.31. ERS Genomics Licenses CRISPR-Cas9 Patents to Axxam

7. Profiles of Key Cell Based Assay Companies

  • 7.1. Abcam
  • 7.2. Agilent
  • 7.3. Aurora Biomed
  • 7.4. Axxam
  • 7.5. Beckman Coulter Diagnostics
  • 7.6. Becton, Dickinson and Company
  • 7.7. Berkley Lights
  • 7.8. BioIVT
  • 7.9. Bio-Rad Laboratories, Inc.
  • 7.10. BMG Labtech
  • 7.11. Bruker
  • 7.12. Cell Biolabs, Inc.
  • 7.13. Cell Signaling Technology, Inc.
  • 7.14. Charles River Laboratories
  • 7.15. Corning, Inc.
  • 7.16. Cytek Biosciences
  • 7.17. Cytovale
  • 7.18. Deepcell
  • 7.19. Enzo Biochem
  • 7.20. Eurofins DiscoverX Corporation
  • 7.21. Evotec AG
  • 7.22. Excellerate Bioscience
  • 7.23. Fujifilm Cellular Dynamics International
  • 7.24. Genedata
  • 7.25. Hemogenix
  • 7.26. Invivogen
  • 7.27. Leica Biosystems
  • 7.28. Lonza Group Ltd.
  • 7.29. Luminex Corp (DiaSorin)
  • 7.30. Merck & Co., Inc
  • 7.31. Miltenyi Biotec
  • 7.32. Molecular Devices
  • 7.33. Nanion
  • 7.34. Ncardia
  • 7.35. New England Biolabs, Inc.
  • 7.36. Novogene Bioinformatics Technology Co., Ltd.
  • 7.37. Olympus
  • 7.38. Origene Technologies
  • 7.39. Promega
  • 7.40. Qiagen
  • 7.41. Reaction Biology
  • 7.42. Recursion Pharma
  • 7.43. Revvity
  • 7.44. Roche Diagnostics
  • 7.45. Sartorius
  • 7.46. Sartorius-ForteBio
  • 7.47. Sartorius-IntelliCyt
  • 7.48. Singleron Biotechnologies
  • 7.49. Sony Biotechnology
  • 7.50. SPT Labtech
  • 7.51. Stemcells Technologies Canada Inc.
  • 7.52. Tecan
  • 7.53. Thermo Fisher Scientific Inc.
  • 7.54. Vitro Biopharma

8. Global Market Size

  • 8.1. Global Market Overview by Country
    • 8.1.1. Table - Global Market by Country
    • 8.1.2. Chart - Global Market by Country
  • 8.2. Global Market by User - Overview
    • 8.2.1. Table - Global Market by User
    • 8.2.2. Chart - Global Market by User - Base/End Year Comparison
    • 8.2.3. Chart - Global Market by User - Base Year
    • 8.2.4. Chart - Global Market by User - End Year
    • 8.2.5. Chart - Global Market by User - Share by Year
  • 8.3. Global Market by Product Class - Overview
    • 8.3.1. Table - Global Market by Product Class
    • 8.3.2. Chart - Global Market by Product Class - Base/End Year Comparison
    • 8.3.3. Chart - Global Market by Product Class - Base Year
    • 8.3.4. Chart - Global Market by Product Class - End Year
    • 8.3.5. Chart - Global Market by Product Class - Share by Year

9. Global Market by User Type

  • 9.1. Pharma
    • 9.1.1. Table Pharma - by Country
    • 9.1.2. Chart - Pharma Growth
  • 9.2. Research
    • 9.2.1. Table Research - by Country
    • 9.2.2. Chart - Research Growth
  • 9.3. Industry/Cosmetic
    • 9.3.1. Table Industry/Cosmetic - by Country
    • 9.3.2. Chart - Industry/Cosmetic Growth

10. Cell Based Assay by Product Class

  • 10.1. Instrument
    • 10.1.1. Table Instrument - by Country
    • 10.1.2. Chart - Instrument Growth
  • 10.2. Reagent
    • 10.2.1. Table Reagent - by Country
    • 10.2.2. Chart - Reagent Growth
  • 10.3. Services
    • 10.3.1. Table Services - by Country
    • 10.3.2. Chart - Services Growth
  • 10.4. Software
    • 10.4.1. Table Software - by Country
    • 10.4.2. Chart - Software Growth

11. Appendices

  • 11.1. FDA Cancer Drug Approvals by Year
  • 11.2. Clinical Trials Started
  • 11.3. Share of Pharma R&D by Country

Table of Tables

  • Table 1: The Large Variety of Cell Lines
  • Table 2: Some Common Viability Assays
  • Table 3: Oxidative Stress Related Diseases
  • Table 4: Important Signalling Pathways
  • Table 5: Market Players by Type
  • Table 6: Five Factors Driving Growth
  • Table 7: Three Factors Limiting Growth
  • Table 8 - Global Market by Region
  • Table 9: Global Market by User
  • Table 10: Global Market by Product Class
  • Table 11: Pharma by Country
  • Table 12: Research by Country
  • Table 13: Industry/Cosmetic by Country
  • Table 14: Instrument by Country
  • Table 15: Reagent by Country
  • Table 16: Services by Country
  • Table 17: Software by Country

Table of Figures

  • Figure 1: Reasons for clinical Failure by Phase
  • Figure 2: Immunotherapy Clinical Trial Growth
  • Figure 3: Pharmaceutical Research Expenditures ($Billion)
  • Figure 4: Oxidative Stress and Free Radical Toxicity
  • Figure 5: FDA Cancer Drug Approvals
  • Figure 6: The Changing Approach to Cancer Diagnostics
  • Figure 7: Growth rates of Cell Based Assays by Product Class
  • Figure 8: Global Market Share Chart
  • Figure 9: Global Market by User - Base vs. End Year
  • Figure 10: Global Market by User Base Year
  • Figure 11: Global Market by User End Year
  • Figure 12: User Share by Year
  • Figure 13: Global Market by Product Class - Base vs. End Year
  • Figure 14: Global Market by Product Class Base Year
  • Figure 15: Global Market by Product Class End Year
  • Figure 16: Product Class Share by Year
  • Figure 17: Pharma Growth
  • Figure 18: Research Growth
  • Figure 19: Industry/Cosmetic Growth
  • Figure 20: Instrument Growth
  • Figure 21: Reagent Growth
  • Figure 22: Services Growth
  • Figure 23: Software Growth
  • Figure 24: FDA Cancer Drug Approvals by Year
  • Figure 25: Clinical Trials for Immunotherapy by Year
  • Figure 26: Share of Pharma R&D by Country